1. Regenerative medicine – going faster slowly

    Interviewee/Contributer: Hugh Ilyine

    Organisation: Ilyine Ltd

    Read more

  2. Max Planck bridges the innovation gap

    Interviewee/Contributer: Ulrich Mahr

    Organisation: Max-Planck- Innovation GmbH

    Read more

  3. For Bioalliance Pharma delivery is the innovation

    Interviewee/Contributer: Dominique Constantini

    Organisation: BioAlliance

    Read more

  4. Novo Nordisk Biotech Fund

    Interviewee/Contributer: Johannes Jensen

    Organisation: Novo Nordisk Biotech Fund

    Read more

  5. For BioAlliance Pharma delivery is innovation

    Interviewee/Contributer: Dominique Costantini

    Organisation: BioAlliance Pharma SA

    Read more

  6. TiGenix cell therapy makes regulatory history

    Interviewee/Contributer: Gil Beyen

    Organisation: TiGenix NV

    Read more

  7. Update on US funding for stem cell research

    Interviewee/Contributer: Jennifer Hannesschlager

    Organisation: McKenna, Long & Aldridge

    Read more

  8. Alternative funding strategies for biotech

    Interviewee/Contributer: Michael Nowak

    Organisation: Yorkville Advisors

    Read more

  9. Unwinding the mystery behind TGN1412 -- New preclinical tests for immunology drugs

    Interviewee/Contributer: Stephen Poole

    Organisation: National Institute for Biological Standards and Control

    Read more

  10. AXA Framlington looks for a bottom in biotech

    Interviewee/Contributer: Andy Smith

    Organisation: AXA Framlington Biotech Fund

    Read more